COVID-19-induced transaminitis and hyperbilirubinemia: Presentation and outcomes.

Said, Zeinab Nabil Ahmed; El Habashy, Safinaz Adel; Zaky, Samy

Said, Zeinab Nabil Ahmed; El Habashy, Safinaz Adel; Zaky, Samy.

Afiliação

Said ZNA; Department of Medical Microbiology and Immunology, Faculty of Medicine (For Girls), Al-Azhar University, Cairo 11754, Nasr City, Egypt. znabil58@yahoo.com.
El Habashy SA; Department of Pediatrics, Ain Shams University, Cairo 11391, Abbaseia, Egypt.
Zaky S; Department of Hepato-gastroenterology and Infectious Diseases, Faculty of Medicine (For Girls), Al-Azhar University, Cairo 11754, Egypt.

World J Gastroenterol ; 29(7): 1123-1130, 2023 Feb 21.

Article em En | MEDLINE | ID: mdl-36926664

Assuntos

COVID-19; Hepatopatias; Humanos; COVID-19/complicações; Hiperbilirrubinemia/etiologia; Hepatopatias/diagnóstico; Hepatopatias/epidemiologia; Hepatopatias/etiologia; Pandemias; SARS-CoV-2

Palavras-chave

COVID-19; Hyperbilirubinemia; Liver injury; Pathophysiology; SARS-CoV-2; Transaminases

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: COVID-19 / Hepatopatias Tipo de estudo: Diagnostic_studies / Etiology_studies Limite: Humans Idioma: En Revista: World J Gastroenterol Assunto da revista: GASTROENTEROLOGIA Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Egito

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google